Thursday, May 29, 2025
New Pulmonary Arterial Hypertension Treatment Offers Hope for Patients in Advanced Stage of Disease
A relatively new therapy used to treat pulmonary arterial hypertension in those with mild to moderate disease was found to be effective at preventing death in those with more advanced disease. Results were published on Wednesday, May 28, in The New England Journal of Medicine and could have “transformative implications” for patients, according to an editorial that accompanied the study written by Bradley Maron, MD, Professor of Medicine and Director of the Hypertension Program at the University of Maryland School of Medicine.
Friday, May 23, 2025
Kahlert Institute for Addiction Medicine Finds Innovative Approaches to Fighting Fourth Wave of Opioid Public Health Crisis
As the U.S. battles a fourth wave of a drug overdose public health crisis that is claiming 300 lives a day, the University of Maryland School of Medicine’s Kahlert Institute for Addiction Medicine marks two years since its founding with a renewed sense of mission and purpose: to find new treatments and approaches to discovery that will save lives and reverse the stigma associated with addiction.
Thursday, May 15, 2025
Using Testosterone Gel to Treat Women Recovering from Hip Fractures Provides No Added Benefits, Clinical Trial Finds
Hip fractures, often a result of a fall, are the most serious type of osteoporotic fracture because they are accompanied by considerable pain, loss of muscle and bone strength, reduced mobility and independence with daily activities, and increased risk for future fractures and death. More than 200,000 American women every year experience hip fractures, and up to three-quarters of them never fully regain their ability to resume normal activities like walking, even after undergoing weeks of exercise rehabilitation. In a pressing effort to test new treatments, researchers conducted a clinical trial to see whether applying a testosterone gel with exercise could improve function and mobility in these patients.
Wednesday, May 14, 2025
Nationally Recognized Emergency Radiologist Tarek Hanna, MD, Named New Chair of Diagnostic Radiology & Nuclear Medicine at the University of Maryland School of Medicine
UMSOM Dean Mark T. Gladwin, MD, announced today that Tarek N. Hanna, MD, FASER, a nationally recognized expert in emergency and trauma radiology, has been named the new Chair of UMSOM’s Department of Diagnostic Radiology & Nuclear Medicine, President of University of Maryland Diagnostic Imaging Specialists and Chief of Diagnostic Radiology and Nuclear Medicine Clinical Service at University of Maryland Medical Center, following a national search.
Monday, May 12, 2025
UMGCCC Researchers Share New Findings on Link Between Lifetime Alcohol Use and Colorectal Cancer and More at AACR 2025
University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) researchers, who are on faculty at the University of Maryland School of Medicine, presented findings at the American Association for Cancer Research (AACR) Annual Meeting in Chicago last month.
Tuesday, May 06, 2025
In First-of-Its-Kind Surgery, Rare Spinal Tumor Removed Through Patient’s Eye Socket at University of Maryland Medical Center
In a first-of-its-kind surgery, a team led by a University of Maryland Medical Center (UMMC) neurosurgeon has successfully removed a rare cancerous tumor wrapped around the spine and spinal cord of a 19-year-old woman – through her eye socket (orbit).
Tuesday, May 06, 2025
UM Medical Alumni Association Honors Maurice Reid ‘99 and Diana Rickard ‘05
The Medical Alumni Association of the University of Maryland, Inc. (MAA) honored two outstanding physicians, Maurice N. Reid, MD, ’99 and Diana G. Rickard, MD, '05, for their transformative impacts in medicine at the 150th Harry & Vivian Kramer Awards Luncheon & Business Meeting on May 2.
Monday, April 28, 2025
New Innovation Alliance Aims to Drive New Med Tech Ventures In Region
and investors together with physician-scientists, surgeons, and medical technologists promises to launch the Baltimore region as a major national hub for new biomedical ventures and start-up companies. The initiative, called the “Innovation Alliance,” leverages the region's national and international leadership in biomedical research and technology to attract venture capital, foster startups, drive economic growth, and ultimately bring to market new treatments, cures, and technologies that will directly improve lives.
Tuesday, April 22, 2025
While AI Could Be the Game Changer in Predicting Health Outcomes It Should Not Be the Only Method
With the advent of artificial intelligence (AI), predictive medicine is becoming an important part of healthcare, especially in cancer treatment. Predictive medicine uses algorithms and data to help doctors understand how a cancer might continue to grow or react to specific drugs—making it easier to target precision treatment for individual patients.
Thursday, April 17, 2025
Faculty Address Future of Federal Research Funding in National Media Panel
Researchers at the University of Maryland, Baltimore addressed members of the media on Thursday, April 3 to discuss ongoing impacts of cuts to federally funded medical research and the future of academic medicine. From the potential of GLP-1 antagonists, like Ozempic, in addiction medicine to blood tests for early cancer diagnosis, researchers provided reporters an inside look at how lifesaving interventions could be hampered by the loss of federal funding.